Development and Characterization of Soy Lecithin Liposome as Potential Drug Carrier Systems for Codelivery of Letrozole and Paclitaxel
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development and Characterization of Soy Lecithin Liposome as Potential Drug Carrier Systems for Codelivery of Letrozole and Paclitaxel
Authors
Keywords
-
Journal
Journal of Nanomaterials
Volume 2020, Issue -, Pages 1-9
Publisher
Hindawi Limited
Online
2020-12-31
DOI
10.1155/2020/8896455
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Folic acid receptor-targeted solid lipid nanoparticles to enhance cytotoxicity of letrozole through induction of caspase-3 dependent-apoptosis for breast cancer treatment
- (2020) Atefeh Yassemi et al. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- Composition design and medical application of liposomes
- (2019) Mingyuan Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Short and Long-Term Effects of the Exposure of Breast Cancer Cell Lines to Different Ratios of Free or Co-Encapsulated Liposomal Paclitaxel and Doxorubicin
- (2019) Franco et al. Pharmaceutics
- Cytotoxic Effect of Paclitaxel and Lapatinib Co-Delivered in Polylactide-co-Poly(ethylene glycol) Micelles on HER-2-Negative Breast Cancer Cells
- (2019) Alicja Zajdel et al. Pharmaceutics
- Formulation and evaluation of letrozole-loaded spray dried liposomes with PEs for topical application
- (2019) Mithun Maniyar et al. JOURNAL OF LIPOSOME RESEARCH
- Gemcitabine Combination Nano Therapies for Pancreatic Cancer
- (2019) Kamalika Samanta et al. Pharmaceutics
- Nitroxide radical-containing nanoparticles attenuate tumorigenic potential of triple negative breast cancer
- (2018) Babita Shashni et al. BIOMATERIALS
- Arginine, glycine, aspartic acid peptide-modified paclitaxel and curcumin co-loaded liposome for the treatment of lung cancer: in vitro/vivo evaluation
- (2018) Kanqiu Jiang et al. International Journal of Nanomedicine
- Preparation and characterization of letrozole-loaded poly(d,l-lactide) nanoparticles for drug delivery in breast cancer therapy
- (2018) Bayan Alemrayat et al. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- Adapting liposomes for oral drug delivery
- (2018) Haisheng He et al. Acta Pharmaceutica Sinica B
- Development of Dual Drug Loaded Nanosized Liposomal Formulation by A Reengineered Ethanolic Injection Method and Its Pre-Clinical Pharmacokinetic Studies
- (2018) Muhammad Sarfraz et al. Pharmaceutics
- Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides
- (2017) Jiawei Sun et al. International Journal of Nanomedicine
- Development of antiproliferative long-circulating liposomes co-encapsulating doxorubicin and curcumin, through the use of a quality-by-design approach
- (2017) Lucia Ruxandra Tefas et al. Drug Design Development and Therapy
- Tumor-Associated Macrophages Suppress the Cytotoxic Activity of Antimitotic Agents
- (2017) Oakley C. Olson et al. Cell Reports
- Redox and pH Responsive Poly (Amidoamine) Dendrimer-Heparin Conjugates via Disulfide Linkages for Letrozole Delivery
- (2017) Thanh Luan Nguyen et al. Biomed Research International
- Liposomal Formulations in Clinical Use: An Updated Review
- (2017) Upendra Bulbake et al. Pharmaceutics
- Clinical utility of letrozole in the treatment of breast cancer: a Chinese perspective
- (2016) Xin Ma et al. OncoTargets and Therapy
- Kinetic Analysis of Drug Release From Nanoparticles
- (2016) Mohammad Barzegar-Jalali JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Combination Therapy using Co-encapsulated Resveratrol and Paclitaxel in Liposomes for Drug Resistance Reversal in Breast Cancer Cells in vivo
- (2016) Jie Meng et al. Scientific Reports
- Release kinetics of paclitaxel and cisplatin from two and three layered gold nanoparticles
- (2015) Christopher G. England et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- PEGylated liposomes of anastrozole for long-term treatment of breast cancer:in vitroandin vivoevaluation
- (2015) Gopal Venkatesh Shavi et al. JOURNAL OF LIPOSOME RESEARCH
- The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study
- (2015) Richard S Finn et al. LANCET ONCOLOGY
- Mathematical models in drug delivery: How modeling has shaped the way we design new drug delivery systems
- (2014) Nicholas A. Peppas et al. JOURNAL OF CONTROLLED RELEASE
- Application of liposomes in medicine and drug delivery
- (2014) Hadis Daraee et al. Artificial Cells Nanomedicine and Biotechnology
- Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC)
- (2012) J. Siepmann et al. ADVANCED DRUG DELIVERY REVIEWS
- Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
- (2012) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Lapatinib plus Letrozole as First-Line Therapy for HER-2+ Hormone Receptor-Positive Metastatic Breast Cancer
- (2010) L. S. Schwartzberg et al. ONCOLOGIST
- Celecoxib-loaded liposomes: effect of cholesterol on encapsulation andin vitrorelease characteristics
- (2009) Asli Deniz et al. BIOSCIENCE REPORTS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started